Over 600,000 adults in the US suffer from ESRD. For the appropriate patients, kidney transplantation (KT) reduces mortality, improves quality of life, and saves substantial Medicare dollars. However, selecting patients for KT can be challenging, particularly among certain subgroups such as older adults, and current metrics are of limited utility in informing clinical decision-making. Furthermore, once selected for KT, patients face similar challenges when considering deceased donor offers or deciding if to allow friends or family to put themselves at risk as living donors. Predicting which patients would benefit from KT, and optimally matching them to the right donor, is one of the most critical concerns for patients, transplant physicians, and referring nephrologists. This is a proposal for a K24 Midcareer Investigator Award for Dorry Segev, MD, PhD, an Associate Professor of Surgery and Epidemiology at Johns Hopkins University. Dr. Segev leads three major R01-funded patient- oriented research efforts to address the challenges of ESRD and KT clinical decision-making: (1) A prospective study of frailty and risk prediction among older dialysis patients and kidney transplant recipients; (2) A retrospective study of long-term outcomes and survival benefit from incompatible live donor kidney transplantation; and (3) A multi-center longitudinal study of long-term sequelae of kidney donation. In addition to addressing the aims of the individual grants, these studies provide rich substrate for ancillary studies by mentees, including thousands of patients engaged in several cohorts, as well as many opportunities for advanced methodologic training. Dr. Segev is actively mentoring students, residents, fellows, and junior faculty in an exciting, productive multidisciplinary environment. This K24 will afford future mentees the opportunity to leverage Dr. Segev's rich ongoing research portfolio with the following new aims: (1) To better understand dialysis and KT outcomes important to older adults; (2) To quantify secondary risks of incompatible KT protocols; (3) To elucidate familial, genetic, and non-renal risks after kidney donation; (4) To design models to assist KT candidates with organ offer decisions; and (5) To expand Dr. Segev's capacity to mentor the next generation of clinician-scientists in ESRD and KT by pursuing formal training in mentoring, learning leadership skills from experts at JHU, continuing to foster multidisciplinary collaborations across the institution, connecting with mentors and mentees from across the country, and refining a curriculum for teaching patient-oriented research to surgeons and other clinicians

Public Health Relevance

Predicting which patients would benefit from kidney transplantation, and best matching them to the right kidney donor, is one of the most critical concerns for patients, transplant physicians, and referring nephrologists. This award will allow Dorry Segev, MD, PhD and his team of mentees to better understand risk prediction by examining outcomes important to older adults, risks of immunosuppression associated with transplantation, and risks of donating a kidney. It will also support Dr. Segev's training of new investigators to study ways to improve the health of patients with kidney disease through rigorous patient-oriented research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24DK101828-03
Application #
9064768
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK-D)
Program Officer
Abbott, Kevin C
Project Start
2014-04-15
Project End
2019-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
3
Fiscal Year
2016
Total Cost
$184,338
Indirect Cost
$13,655
Name
Johns Hopkins University
Department
Surgery
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Ruck, Jessica M; Segev, Dorry L (2018) Expanding deceased donor kidney transplantation: medical risk, infectious risk, hepatitis C virus, and HIV. Curr Opin Nephrol Hypertens 27:445-453
Van Pilsum Rasmussen, Sarah; Konel, Jonathan; Warsame, Fatima et al. (2018) Engaging clinicians and patients to assess and improve frailty measurement in adults with end stage renal disease. BMC Nephrol 19:8
McAdams-DeMarco, Mara A; Ying, Hao; Van Pilsum Rasmussen, Sarah et al. (2018) Prehabilitation prior to kidney transplantation: Results from a pilot study. Clin Transplant :e13450
Jackson, Kyle R; Covarrubias, Karina; Holscher, Courtenay M et al. (2018) The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS. Am J Transplant :
Lai, Jennifer C; Segev, Dorry L; McCulloch, Charles E et al. (2018) Physical frailty after liver transplantation. Am J Transplant 18:1986-1994
Haugen, Christine E; King, Elizabeth A; Bae, Sunjae et al. (2018) Early Hospital Readmission in Older and Younger Kidney Transplant Recipients. Am J Nephrol 48:235-241
Haugen, Christine E; Holscher, Courtenay M; Garonzik-Wang, Jacqueline et al. (2018) National Trends in Liver Transplantation in Older Adults. J Am Geriatr Soc 66:2321-2326
Doby, Brianna L; Tobian, Aaron A R; Segev, Dorry L et al. (2018) Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma. Curr Opin Organ Transplant 23:271-278
Shaffer, Ashton A; Thomas, Alvin G; Bowring, Mary Grace et al. (2018) Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey. Transpl Infect Dis 20:e12982
Ruck, Jessica M; Zhou, Sheng; Thomas, Alvin G et al. (2018) Electronic messaging and communication with living kidney donors. Clin Transplant 32:

Showing the most recent 10 out of 123 publications